Can Statins Augment SSRIs?
Combining statins with a selective serotonin reuptake inhibitor (SSRI) might lower the risk for and symptoms of depression.
Lithium Intoxication: A New Study
Lithium toxicity is uncommon, but clinicians should test lithium blood levels when indicated and discuss risks with patients during treatment planning.
Whole-Body Hyperthermia for MDD?
Preliminary data suggest whole-body hyperthermia should be tested further as a potential new treatment for depression.
Large Study Shows Decline in Dementia Prevalence in the United States between 2000 and 2012; Transitions to Daylight Savings Time Is Associated with an Increase in Depression
Oral Health in Patients with Mood and Anxiety Disorders
Patients with psychiatric disorders should be regularly screened for oral health and referred for dental care as needed.
Testosterone Supplementation: More Negative Evidence
A literature review of 156 studies concluded that the benefits of testosterone supplementation do not outweigh the risks for any population of normal men.
About the BTP Newsletter
Our subscribers say BTP is…
"Very relevant, practical, and thought-provoking."
"About the only thing left without drug ads...objective and balanced."
"Succinct, readable, clear, timely and relevant!"
"Well written and scientifically sound."
Originating at the Massachusetts General Hospital and Harvard Medical School, Biological Therapies in Psychiatry has been a trusted resource for physicians for over 30 years. Described as "influential" by the Atlantic Monthly, this concise, four-page, monthly newsletter provides up-to-date information about the rapidly expanding field of psychotropic medications and other biological treatments for mental disorders.
From his perspective as an editor, teacher, investigator, and clinician, Alan J. Gelenberg, M.D., reviews the widespread literatures of science and clinical practice. Dr. Gelenberg distills the material most relevant for a busy practitioner and presents it each month with a balance of scientific curiosity, healthy skepticism, and clinical experience.
Dr. Gelenberg is Professor and Interim Chair of Psychiatry at Penn State, Hershey. Since 1987, Dr. Gelenberg has been Editor-in-Chief of the Journal of Clinical Psychiatry, and he recently chaired the workgroup that revised the American Psychiatric Association's major depressive disorder guidelines. Dr. Gelenberg has been on the faculty of Harvard Medical School, MIT, and the University of Arizona and has written numerous scientific articles and book chapters on mood disorders, depression, and schizophrenia. He is listed in the Best Doctors in America and America's Top Doctors and received the 1997 Exemplary Psychiatrist Award of the National Alliance for the Mentally Ill.
We offer both print and online subscriptions. Our web site provides subscribers with 24-hour access to archives as well as current issues. In addition, Continuing Medical Education credit is available for reading BTP. You can earn up to 12.0 hours in category 1 credit by answering questions in the December issue about topics covered during the year.